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The aim of this study was to determine after 52 weeks whether advice to follow a lower carbohydrate diet, either high in monounsaturated fat or
low fat, high in protein had differential effects in a free-living community setting. Following weight loss on either a high monounsaturated fat,
standard protein (HMF; 50% fat, 20% protein (67g/d), 30% carbohydrate) or a high protein, moderate fat (HP) (40% protein (136g/d), 30%
fat, 30% carbohydrate) energy-restricted diet (6000 kJ/d) subjects were asked to maintain the same dietary pattern without intensive dietary coun-
selling for the following 36 weeks. Overall weight loss was 6·2 (SD 7·3) kg (P,0·01 for time with no diet effect, 7·6 (SD 8·1) kg, HMF v. 4·8 (SD
6·6) kg, HP). In a multivariate regression model predictors of weight loss at the end of the study were sex, age and reported percentage energy from
protein (R
2 0·22, P,0·05 for the whole model). Fasting plasma insulin decreased (P,0·01, with no difference between diets), 13·9 (SD 4·6) to 10·2
(SD 5·2) mIU/l, but fasting plasma glucose was not reduced. Neither total cholesterol nor LDL-cholesterol were different but HDL was higher, 1·19
(SD 0·26) v. 1·04 (SD 0·29) (P,0·001 for time, no diet effect), while TAG was lower, 1·87 (SD 1·23) v. 2·22 (SD 1·15) mmol/l (P,0·05 for time, no
diet effect). C-reactive protein decreased (3·97 (SD 2·84) to 2·43 (SD 2·29) mg/l, P,0·01). Food records showed that compliance to the prescribed
dietary patterns was poor. After 1 year there remained a clinically signiﬁcant weight loss and improvement in cardiovascular risk factors with no
adverse effects of a high monounsaturated fat diet.
Protein: Weight loss: Carbohydrate: HDL-cholesterol
CVD is strongly associated with obesity and there is evidence
that sustained weight loss has positive effects on disease risk
factors (Avenell et al. 2004). In general, weight loss studies
of 3–6 months will be focused on weight loss as a primary
outcome while studies of 6–12 months or more focus on
maintenance of the early weight loss. There are few studies
of 6 months duration or more to establish whether weight
loss is preferentially maintained on higher protein diets
(Foster et al. 2003; Brinkworth et al. 2004a; Due et al.
2004; Stern et al. 2004; Lejeune et al. 2005). Lejeune et al.
(2005) showed improved weight maintenance when protein
was 18% of energy compared to 15% in a 6-month study.
However, Due et al. (2004) observed that while weight loss
was greater after 6 months on a higher protein diet compared
to a conventional low fat diet at 6 months, this difference was
not sustained at 12 months. The high protein group had a
greater abdominal fat loss suggesting a long-term metabolic
advantage of the diet. In a study of weight maintenance
from our group of either a high protein or high carbohydrate
diet, fat loss of ,3kg was maintained as were improvements
in CVD risk factors without any effect of diet (Brinkworth
et al. 2004a). Foster et al. (2003) reported greater weight
loss at 6 months in subjects on a very low carbohydrate,
high protein, high fat diet but there was no difference at 12
months. Stern et al. (2004) also found that weight loss at 1
year was not different in subjects advised to follow a low
carbohydrate (,30g/d) compared to a conventional diet.
There were differential effects such that TAG decreased
more and HDL-cholestrol decreased less on the low carbo-
hydrate diet, suggesting there may be some long-term meta-
bolic beneﬁts of this dietary pattern. It is thought that a high
fat intake per se will promote weight gain and low fat
weight loss diets are the recommended option (Astrup et al.
2000). However, a high MUFA diet is recommended for
people with metabolic syndrome and diabetes in order to
avoid the TAG-increasing and HDL-cholestrol-lowering
effects of low fat diets (Garg et al. 1998). Despite this, to
our knowledge there are few, if any, studies of the long-
term effect of a reduced carbohydrate, high monounsaturated
fat diet. Therefore the aim of the present study was to evaluate
the long-term effects of, and compliance to, carbohydrate-
restricted diets high in either monounsaturated fat or protein,
on weight loss, body composition and risk factors for CHD
in a 52-week outpatient study. We hypothesised that in the
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on maintenance of weight loss and markers of CVD risk.
We also hypothesised that the blood pressure fall would be
greater on the high protein diet. The present study was a
follow-up of a previously published short-term weight loss
study which was conducted under close supervision and we
did not expect, nor ﬁnd, a differential weight loss under
those circumstances (Luscombe-Marsh et al. 2005).
Study design and methods
Obese hyperinsulinaemic subjects (20–65 years, BMI
27–40kg/m
2), recruited by public advertisement, were included
if fasting serum insulin was greater than 15mIU/l. They were
excluded if they had diabetes mellitus (on history or fasting
blood sugar .7mmol/l at baseline), a history of liver,
unstable cardiovascular, respiratory or gastrointestinal disease,
malignancy, or were pregnant or lactating. The study protocol
wasapprovedbytheHumanEthicsCommitteesoftheCommon-
wealth Scientiﬁc Industrial Research Organisation and the Royal
Adelaide Hospital and subjects provided informed written
consent. Seventy-three subjects were randomised and thirty-
eight completed the 52-week study. Baseline characteristics for
these subjects are presented in Table 1.
Experimental protocol
Inanoutpatientrandomisedparallel-designedstudysubjectswere
prescribed energy restricted (6000 kJ) diets that were either high
monounsaturated fat (HMF), 50% of energy as fat, 76g/d and
20% of energy as protein (67g/d) or high protein (HP), 40% of
energy as protein, 136g/d, carbohydrate was restricted to 30%
of energy (110g/d) and saturated fat ,10% of energy in both
diets. Data from the 1995 Australian National Nutrition Survey
(Australian Bureau of Statistics, 1997) indicates that the usual
percentage energy from protein intake is 18% for adults and the
standard protein diet was consistent with this.
Following an intensive phase of 16 weeks with visits every 2
weeks, subjects were asked to continue the same diet and were
seen every 12 weeks for dietary counselling, fasting blood
samples and calculation of a 3 d weighed food record collected
during the week before their visit. The weighed food records
were analysed using Diet/1 Nutrient Calculation software
(Xyris Software 1998, Highgate Hill, Australia). At weeks 0,
28,40and 52, weight and resting bloodpressure were measured
and fasting venous blood samples taken for glucose, insulin,
lipids, serum creatinine and C-reactive protein (CRP), and
analysed as previously described (Luscombe-Marsh et al.
2005). Those subjects with a CRP $ 10mg/l at any time-point
were excluded from the analysis. The Homeostasis Model
Assessment index of insulin sensitivity was calculated (fasting
insulin concentration (mU/ml) £ fasting glucose concentration
(mmol/l)/22·5) at the beginning and end of the study. A 24h
urine sample was collected for urea/creatinine ratio, calcium
and sodium excretion, deoxy-pyridinoline/creatinine and pyr-
idinoline/creatinine, and analysed as previously described
(Luscombe-Marsh et al. 2005). The 24h urine urinary urea
and urea/creatinine ratio were used to assess compliance with
the high or low protein intake.
Body weight and body composition
Body weight and body composition (dual-energy X-ray
absorptiometry) were measured as previously described at
weeks 0 and 52 (Luscombe-Marsh et al. 2005).
Statistical analyses
Statistical analysis was performed using SPSS for Windows
version 10.0 software (SPSS Inc., Chicago, IL, USA).
The effect of the diet intervention was assessed using
repeated-measures ANOVA for each variable, with time as the
within-subject factor and diet as the between-subject factor.
Power
The study had 80% power (a 0·05) to detect differences
between groups of 3·6kg in body weight, 0·9kg in lean
mass, 3 mIU/l in fasting insulin and 0·2mmol/l in LDL-choles-
terol. Signiﬁcance was set at P,0·05. All data are presented as
means and standard deviations unless otherwise stated.
Results
Weight
Weight loss from baseline for the thirty-eight subjects who
completed the study was 6·2 (SD 7·3) kg (P,0·01 for time
with no diet effect, 7·6 (SD 8·1) v. 4·8 (SD 6·6) kg HMF v.
HP, respectively). Weight regain from week 16 to week 52
was 3·8 (SD 4·5) kg (P,0·001 for time with no diet effect,
2·6 (SD 4·4) v. 4·9 (SD 4·4) kg HMF v. HP). When an intention
to treat analysis was performed with baseline weight carried
forward for the dropouts, weight loss was 4·1 (SD 6·7) kg
(P,0·01 for time with no diet effect). Weight at weeks 28,
40 and 52 is presented in Table 2.
To assess whether there were differences in weight loss if pro-
tein intake remained high at the end of the study, the group was
divided by the median reported protein intake into two groups
with an average intake of 75 (SD 12) g (19 (SD 3) %) and 111
(SD 19) g (23 (SD 4) %) protein. Weight loss was 6·4 (SD 6·7) kg
in the low protein reporters v. 7·0 (SD 8·1) kg in the high protein
reporters(NS);macronutrientintakewasconﬁrmedbyurea/crea-
tinine excretion (27·6 (SD 7·4) v.3 3 · 9( SD 5·8), P,0·05).
Body composition
Twenty-ﬁve subjects attended for body composition measure-
ments, eleven HMF (three male) and fourteen HP (ﬁve male),
Table 1. Subject characteristics at baseline
(Mean values and standard deviations)
HP (n 19) HMF (n 19) Total (n 38)
Mean SD Mean SD Mean SD
Age (years) 48 13 52 8 50 11
Weight (kg) 99 15 93 12 96 13
BMI (kg/m
2)3 4 4 3 4 4 3 4 4
Insulin (mIU/l) 14·2 5·5 15·9 9·6 15·1 7·8
Glucose (mmol/l) 5·9 2·1 5·4 0·5 5·7 1·5
HMF, high monounsaturated fat, standard protein diet; HP, high protein, moderate
fat diet.
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These subjects had a mean weight loss of 8·1 (SD 6·9) kg with
a fat to lean ratio of 2·5:1 (2·1 (SD 2·7) kg lean mass and 5·2
(SD 5·5) kg fat, P,0·001 for time, with no effect of diet.
Reported dietary intake and dietary compliance
Thirty-ﬁve subjects (sixteen HMF, nineteen HP) completed 3 d
weighedfoodrecords. There was nochangeinenergyornutrient
intake with time during follow-up (Table 3). As expected, men
had higher energy intakes than women throughout follow-up,
9271 (SD 2655) v. 6574 (SD 1292), 8575 (SD 1086) v. 6836 (SD
1127) and 8194 (SD 2493) v. 6721 (SD 883) kJ, men v. women
at 28, 40 and 52 weeks (P,0·001). Overall, HMF subjects
reported lower energy intakes than HP at all time-points
(P,0·01) but this was a function of the higher energy intake in
the men on the HP diet. Reported absolute protein intake was
higher in men (117 (SD 25) v. 93 (SD 25), 113 (SD 28) v. 91 (SD
24) and 102 (SD 25) v. 90 (SD 21) g/d, men v. women at 28, 40
a n d5 2w e e k s( P,0·001)) and remained higher overall in HP at
all time-points (P,0·001). However, there were no differences
whenthe protein intake was expressedasa percentageofenergy.
At the end of the study saturated fat intake was 11 (SD 3) % in
both groups, monounsaturated fat 12 (SD 5) HMF v. 13 (SD3) %
HP (NS) and polyunsaturated fat 5 (SD 2) % in both groups.
In those subjects in the upper half of reported protein intakes,
reported energy intake was also higher (8039 (SD 2298) v. 6427
(SD972)kJ,P¼0·01).However,despitethis,weightlosswasthe
same in both groups at the end of the study.
In a multivariate regression model predictors of weight loss
at the end of the study were sex, age and reported percentage
energy from protein (R
2 0·22, P,0·05 for the whole model).
Urea/creatinine ratio
Overall, there was no difference in urea/creatine ratio between
the groups at baseline (34 (SD 10) v.4 2( SD 11), HMF v. HP)
or at the end of the study (28 (SD 6) v. 34 (SD 7), HMF v. HP).
Markers of bone turnover
The pyridinoline/creatinine ratio was decreased at the end of
the study with no difference between groups (94·00
(SD 38·08) v. 61·45 (SD 18·84) nmol/mmol, baseline v. 52
weeks, P,0·01). The deoxypyridinoline/creatinine ratio was
also decreased (26·39 (SD 10·24) v. 16·48 (SD 6·87), P,0·01
for time, no effect of diet).
The 24h calcium excretion was not different at the end of
the study (3·62 (SD 3·01) v. 3·80 (SD 2·74) mmol/l) with no
differences between groups.
Blood pressure and urinary sodium
Therewasatrendforareductioninsystolicbloodpressureatthe
endofthestudy(130(SD14)v.127(SD13)mmHg,baselinev.52
Table 2. Insulin, glucose, lipids, high sensitivity C-reactive protein (hsCRP) and weight before
and after weight loss†
(Mean values and standard deviations)
Week 0 Week 28 Week 40 Week 52
Mean SD Mean SD Mean SD Mean SD
Insulin (IU/l)
HMF 13·98 5·14 ND ND 10·12** 5·02
HP 13·79 4·26 ND ND 10·28** 5·45
Total 13·88 4·65 ND ND 10·20** 5·16
Glucose (mmol/l)
HMF 5·87 1·93 ND ND 5·69 0·72
HP 5·49 0·44 ND ND 5·39 0·47
Total 5·68 1·41 ND ND 5·55 0·62
Total cholestrol (mmol/l)
HMF 4·91 1·00 4·37 0·79 4·72 0·99 4·84 0·84
HP 5·64 1·19 5·29 1·48 5·27 1·36 5·53 1·48
Total 5·26 1·14 4·84 1·27 5·00 1·21 5·18 1·23
HDL-cholestrol (mmol/l)
HMF 1·00 0·28 1·07 0·20 1·16 0·20 1·16** 0·23
HP 1·09 0·30 1·27 0·28 1·25 0·30 1·23** 0·29
Total 1·04 0·29 1·17 0·26 1·20 0·26 1·19** 0·26
TAG (mmol/l)
HMF 2·27 1·21 1·76 1·26 1·70 1·07 1·84* 1·22
HP 2·17 1·18 1·62 1·06 1·98 1·21 1·86* 1·40
Total 2·22 1·18 1·69 1·14 1·84 1·14 1·85* 1·29
HsCRP (mg/l)
HMF 4·18 2·84 2·76 2·87 3·15 3·28 2·63** 2·14
HP 2·58 1·70 1·72 1·44 1·79 1·52 1·81** 2·22
Total 3·35 2·41 2·22 2·25 2·44 2·56 2·20** 2·17
Weight (kg)
HMF 98·8 15·0 89·0 16·0 90·3 16·4 91·3** 16·6
HP 91·9 11·0 83·0 11·4 85·1 12·0 86·6** 12·5
Total 95·4 13·4 86·0 14·0 87·7 14·3 89·0** 14·7
HMF, high monounsaturated fat, standard protein diet; HP, high protein, moderate fat diet; ND, no data.
Mean values were signiﬁcantly different for week 52 compared with baseline: *P,0·05; **P,0·01.
†For details of procedures, see p. 406.
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pressure was not different (73 (SD 10) v. 74 (SD 10) mmHg).
There was no difference in 24h sodium excretion between
the groups at baseline or 52 weeks (153 (SD 80) v. 177
(SD 59) mmol/24h, baseline v. 52 weeks).
Insulin glucose and NEFA
Fasting plasma insulin was reduced at the end of the study
(P,0·01 for time, no effect of diet, 13·9 (SD 4·6) v. 10·2 (SD
5·2) mIU/l, baseline v. 52 weeks; Table 2). Fasting plasma glu-
cose was not different (Table 2). NEFA were not different at
the end of the study (332 (SD 136) v. 291 (SD 122) mmol/l, base-
line v. 52 weeks). The calculated Homeostasis Model Assess-
ment index (fasting insulin concentration (mU/ml) £ fasting
glucoseconcentration(mmol/l)/22·5)was3·62(SD1·97)atbase-
line and fell to 2·52 (SD 1·34) at the end of the study (P,0·01)
with no difference between diets.
Lipids
At the end of the study HDL-cholestrol was higher overall
with no effect of diet (1·04 (SD 0·29) v. 1·19 (SD 0·26)
mmol/l, P,0·001 for time). TAG was reduced at the end of
the study (2·22 (SD 1·15) v. 1·85 (SD 1·23) mmol/l, P,0·05
for time with no effect of diet), however, neither total choles-
terol nor LDL-cholestrol were different after 52 weeks
(Table 2). Lipids at 28 and 40 weeks are presented in Table 2.
C-reactive protein
There was a reduction in CRP at the end of the study with no
difference between diets (3·97 (SD 2·84) v. 2·43 (SD 2·29) mg/l,
P,0·01). CRP at 28 and 40 weeks are presented in Table 2.
Discussion
The main ﬁnding of the present study was that although
modest carbohydrate restriction was not maintained over the
course of the study subjects maintained a 6kg weight loss
from baseline which was associated with improvements in
the CVD risk markers, namely insulin, HDL-cholestrol,
TAG and CRP, at the end of 52 weeks.
Maintenance of weight loss
Long-term maintenance of weight loss of similar modest
amounts is associated with long-term health beneﬁts, notably
delayingtheonsetoftype2diabetes(Knowleretal.2002;Lind-
strom et al. 2003). However, the regain of approximately 4kg
during the 9 months of follow-up suggests that the subjects
had difﬁculty maintaining reduced energy intake following
weight loss. It may be that the 3-monthly dietary counselling
visits did not provide sufﬁcient support to prevent weight
regain. Longer-term studies where weight loss had been main-
tained include the Finnish Diabetes Prevention Study and the
Diabetes Prevention Program (Knowler et al. 2002; Lindstrom
etal.2003).However,bothofthesestudieshadanexerciseinter-
vention and ongoing support both of which may have been ben-
eﬁcial in helping maintain weight loss.
High monounsaturated fat or high protein intakes were not
maintained during the long-term follow-up. Due et al. (2004)
observedsimilarweightloss,6kg,after12monthsandmainten-
anceofahighproteinintakedemonstratedbyhigher24hurinary
nitrogen excretion. The groups received dietary counselling
every 2 weeks despite which overall weight loss was similar to
thatseeninthepresentstudy.Weightafter2yearswasavailable
for a small number of subjects (n 17) in the earlier study for
whom weight loss was approximately 5kg. The authors report
good dietary compliance judged by food records and urinary
nitrogen excretion and a non-signiﬁcant trend to greater
weight loss in the high protein group. In the present study, sub-
jectsreportinghigherproteinintakesalsoreportedhigherenergy
intakesbuttherewasnodifferenceinweightlosswhenthegroup
was divided by median reported protein intake which was con-
ﬁrmed by urinary urea/creatinine ratio. Lack of compliance to
the dietary prescription may have been due to the diet being dif-
ﬁcult to comply with, the length of the study or both. This has
been observed previously in longer-term studies by our group
and others (Foster et al. 2003; Brinkworth et al. 2004a,b; Due
Table 3. Energy and nutrient intake of the subjects at weeks 28, 40
and 52†
(Mean values and standard deviations)
Week 28 Week 40 Week 52
Mean SD Mean SD Mean SD
Energy (kJ)
HMF 7328* 1878 7209* 1336 6936* 1274
HP 8068 2740 7895 1898 7703 2248
Total 7730 2381 7581 1678 7352 1882
Protein (g)
HMF 92* 19 89* 21 84* 16
HP 113 30 110 30 105 25
Total 104 27 100 28 95 24
Protein (% energy)
HMF 21 4 20 4 20 5
HP 23 6 22 4 22 4
Total 22 5 21 4 21 4
Fat (g)
HMF 73 30 65 19 59 18
HP 72 33 64 23 67 25
Total 72 32 64 21 63 22
Fat (% energy)
HMF 35 8 33 6 31 7
HP 32 8 29 7 32 6
Total 34 8 31 7 32 6
Carbohydrate (g)
HMF 177 48 191 40 192 44
HP 199 82 212 60 198 67
Total 189 68 203 52 195 57
Carbohydrate (% energy)
HMF 41 6 45 7 47 6
HP 42 8 46 8 44 7
Total 42 7 46 7 45 7
Fibre (g)
HMF 28 10 27 7 27 7
HP 27 12 27 12 26 12




T o t a l232323
HMF, high monounsaturated fat, standard protein diet; HP, high protein, moderate
fat diet.
Mean values were signiﬁcantly different from those of the HP group: *P,0·01.
†For details of procedures, see p. 406.
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improvedweightmaintenanceonahigherproteindiet,however,
the extra protein was taken in the form of a supplement which
may have made compliance to the higher protein intake easier.
Body composition
Data on body composition were available only on a subset of
twenty-ﬁve volunteers who attended for dual-energy X-ray
absorptiometry measurement at the end of the study. Overall
they had a slightly greater weight loss of approximately 8kg
because of a smaller weight regain of 1kg, indicating that
they were better able to maintain weight loss than the group
as a whole.
CVD risk
We observed improvements in the CVD risk markers insulin,
CRP, HDL-cholestrol and TAG, with weight loss with no
different between diets. We also saw a trend for a decrease
in systolic blood pressure of 7mmHg from baseline at the
end of the study. Population studies have shown a relationship
between sustained reductions in systolic blood pressure of a
similar amount seen in the present study (8·7mmHg) and
reduction in cardiovascular events (Froom & Goldbourt,
2004). While blood pressure in the range seen in the present
study (the pre-hypertension range deﬁned as 120–139mm
Hg systolic or 80–89mm Hg diastolic blood pressure) is not
independently associated with increased risk of CVD, how-
ever, if added to another risk factor, e.g. obesity, the risk of
CVD increases (Mainous et al. 2004).
Weight loss is associated with improvements in insulin sen-
sitivity and markers of endothelial dysfunction in morbidly
obese and moderately obese subjects (Brinkworth et al.
2004a,b; Vazquez et al. 2005). In the present study, weight
loss alone resulted in a reduction in fasting plasma insulin
of 30% and a lower Homeostasis Model Assessment index
indicating that insulin sensitivity was improved by weight
loss which in turn suggests an improvement in CVD risk.
Lack of effect of diet type on insulin sensitivity and glucose
levels during weight loss has also been reported by other
workers supporting the view that weight loss per se is the
strongest inﬂuence on insulin sensitivity (Johnston et al.
2004, 2006). However, Meckling et al. (2004) observed
improvements in insulin levels only in the low carbohydrate
diet group despite weight loss of approximately 7kg in both
low fat and low carbohydrate dietary groups, suggesting that
there is still some controversy in this area (Johnston et al.
2004, 2006; Meckling et al. 2004). At the end of the present
study there was a net weight loss and reduction in insulin
levels despite lack of compliance to the recommended diets.
The inﬂammatory molecule high sensitivity C-reactive protein
(hsCRP), which is an independent marker for CVD risk, was
40% lower at the end of the study (Ridker et al. 2000). It
has been suggested that CRP should be routinely measured
as part of CVD risk assessment as more than twenty prospec-
tive studies have shown that hsCRP independently predicts
vascular risk and six cohort studies have reported that
hsCRP adds prognostic information beyond that available pre-
viously (Ridker et al. 2004). It has also been reported that
patients on statin treatment who have low CRP levels have
better clinical outcomes than those with higher hsCRP
levels, suggesting that reduction of hsCRP by weight loss
will have a similar beneﬁcial effect (Ridker et al. 2005).
Lipids
HDL-cholestrol levels were 14% higher at the end of the
52-week study with no effect of diet, a phenomenon we
have reported previously (Brinkworth et al. 2004a). Increases
in HDL-cholestrol are associated with reduction in cardiovas-
cular events and a 1% increase in HDL-cholestrol has been
associated with a 3% reduction in death or myocardial infarc-
tion (Boden, 2000). Dattilo & Kris-Etherton (1992) report that
every kilogram of sustained weight loss is associated with a
0·009mmol/l increase in HDL-cholestrol. By these calcu-
lations we should have seen a 0·054mmol/l increase in
HDL-cholestrol instead of which it was greater at approxi-
mately 0·15mmol/l. The overall carbohydrate intake was mod-
erate at approximately 45% energy during follow-up which
may have contributed to this effect (Garg, 1998).
TAG levels remained reduced by 16% at the end of the pre-
sent study also with no effect of diet. Reduction in TAG with
maintenance of weight loss has been reported in a meta-anal-
ysis of seventy studies (Dattilo & Kris-Etherton, 1992). High
TAG is a risk factor for CVD independently of HDL-choles-
terol but it is unclear whether lowering TAG decreases CVD
risk (Hokanson & Austin, 1996; Miller, 2000).
Weighed food records
A limitation of the study was the reliance on 3d weighed food
records to capture dietary intake as it is well known that self-
reporting of dietary intake leads to under-reporting of food
intake and as duration increases so does the inaccuracy (Hill
& Davies, 2001). Reported energy was 8194 (SD 2493) kJ
for the men (97kg) and 6721 (SD 883) kJ for the women
(85kg). Energy requirements were likely to be closer to
11000 kJ for men and 9000kJ based on their weight and an
activity factor of estimated BMR £ 1·4 for a sedentary life-
style. However, the data as reported provides some insight
into the macronutrient proﬁle of the dietary intake at the end
of the study and any error could be expected to be equal
across the group. Men in the high protein group reported
higher energy intakes, however, this was a small number of
men and weight loss was the same overall. This group of
men may have reported their food intake more accurately.
However, it was apparent that both groups had drifted away
from the original dietary pattern as reﬂected by the higher
carbohydrate intakes of approximately 45% which had
increased from the original 30%. A serious limitation of the
study was the high attrition rate although there was no differ-
ence in the number who withdrew or who were lost to follow-
up by diet group. At the end of the study we observed weight
loss which may potentially protect these subjects from
the development of diabetes and improvements in CVD risk
despite reporting a relatively high saturated fat intake
(11 (SD 3) %). It is of interest that a relatively modest carbo-
hydrate restriction was not maintained during the study.
In summary, sustained weight loss at 1 year was associated
with reduction in CVD risk factors with potential long-term
health beneﬁts if maintained. However, limited compliance
Long-term weight maintenance 409to the dietary patterns means that we cannot assess if either
pattern is detrimental or beneﬁcial in the long term.
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